These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Abnormal patterns of sleep and EEG power distribution during non-rapid eye movement sleep in the sheep model of Huntington's disease. Vas S; Nicol AU; Kalmar L; Miles J; Morton AJ Neurobiol Dis; 2021 Jul; 155():105367. PubMed ID: 33848636 [TBL] [Abstract][Full Text] [Related]
10. Girls with attention-deficit/hyperactivity disorder: EEG differences between DSM-IV types. Dupuy FE; Clarke AR; Barry RJ; McCarthy R; Selikowitz M Clin EEG Neurosci; 2011 Jan; 42(1):1-5. PubMed ID: 21309436 [TBL] [Abstract][Full Text] [Related]
11. Computer analysis of EEG activity in dementia of the Alzheimer's type and Huntington's disease. Streletz LJ; Reyes PF; Zalewska M; Katz L; Fariello RG Neurobiol Aging; 1990; 11(1):15-20. PubMed ID: 2139184 [TBL] [Abstract][Full Text] [Related]
12. [Daytime tiredness correlated with nocturnal respiratory and arousal variables in patients with sleep apnea: polysomnographic and EEG mapping studies]. Saletu M; Hauer C; Anderer P; Saletu-Zyhlarz G; Gruber G; Oberndorfer S; Mandl M; Popovic R; Saletu B Wien Klin Wochenschr; 2000 Mar; 112(6):281-9. PubMed ID: 10815304 [TBL] [Abstract][Full Text] [Related]
13. Wake and Sleep EEG in Patients With Huntington Disease: An eLORETA Study and Review of the Literature. Piano C; Mazzucchi E; Bentivoglio AR; Losurdo A; Calandra Buonaura G; Imperatori C; Cortelli P; Della Marca G Clin EEG Neurosci; 2017 Jan; 48(1):60-71. PubMed ID: 27094758 [TBL] [Abstract][Full Text] [Related]
14. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration. Saletu B; Grünberger J; Anderer P; Linzmayer L; König P Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773 [TBL] [Abstract][Full Text] [Related]
15. Memory activation reveals abnormal EEG in preclinical Huntington's disease. van der Hiele K; Jurgens CK; Vein AA; Reijntjes RH; Witjes-Ané MN; Roos RA; van Dijk G; Middelkoop HA Mov Disord; 2007 Apr; 22(5):690-5. PubMed ID: 17266047 [TBL] [Abstract][Full Text] [Related]
16. EEG Functional Connectivity and Cognitive Variables in Premanifest and Manifest Huntington's Disease: EEG Low-Resolution Brain Electromagnetic Tomography (LORETA) Study. Delussi M; Nazzaro V; Ricci K; de Tommaso M Front Physiol; 2020; 11():612325. PubMed ID: 33391027 [TBL] [Abstract][Full Text] [Related]
17. Neurophysiological correlates of non-motor symptoms in late premanifest and early-stage manifest huntington's disease. Davis MC; Hill AT; Fitzgerald PB; Bailey NW; Stout JC; Hoy KE Clin Neurophysiol; 2023 Sep; 153():166-176. PubMed ID: 37506604 [TBL] [Abstract][Full Text] [Related]
18. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia. Saletu B; Grünberger J; Anderer P; Linzmayer L Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258 [TBL] [Abstract][Full Text] [Related]
19. Sex differences between the combined and inattentive types of attention-deficit/hyperactivity disorder: an EEG perspective. Dupuy FE; Barry RJ; Clarke AR; McCarthy R; Selikowitz M Int J Psychophysiol; 2013 Sep; 89(3):320-7. PubMed ID: 23603052 [TBL] [Abstract][Full Text] [Related]
20. Symptom-specific EEG power correlations in patients with obsessive-compulsive disorder. Pogarell O; Juckel G; Mavrogiorgou P; Mulert C; Folkerts M; Hauke W; Zaudig M; Möller HJ; Hegerl U Int J Psychophysiol; 2006 Oct; 62(1):87-92. PubMed ID: 16554100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]